— Know what they know.
Not Investment Advice

CBSC OTC

Cardiac Biotech Solutions Inc.
1W: +12.9% 1M: -12.3% 3M: -12.1% YTD: -12.5% 1Y: -30.0% 3Y: -79.7% 5Y: -91.3%
$0.04
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 42 · $5.8M mcap · 48M float · 0.047% daily turnover · Short 43% of daily vol

Cash Flow Trends

Operating Cash Flow
-$1M -4.9% ▼
Capital Expenditures
$0 +0.0% ▲
Free Cash Flow
-$1M -4.9% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$10K +96.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$999K-$4M-$6M-$2M-$2M
Depreciation & Amort.$0$7K$611$0$0
Stock-Based Comp.$0$0$22K$96K$10K
Change in Working Capital$317K$214K$177K$480K$346K
Other Non-Cash Items-$93K$3M$2M$344K$29K
Operating Cash Flow-$683K-$663K-$786K-$1M-$1M
— Investing Activities —
Capital Expenditures$0$0$0$0$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0-$125K$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0-$125K-$40K$40K$0
Investing Cash Flow$0-$125K-$40K$40K$0
— Financing Activities —
Net Debt Issuance$0$791K$1M$605K$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$600K$0$6K$1K$0
Financing Cash Flow$600K$791K$1M$856K$1M
Net Change in Cash$7K$4K$408K-$291K-$10K
Cash End of Period$15K$19K$427K$136K$126K
Free Cash Flow-$683K-$663K-$786K-$1M-$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms